NCT05828225 Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis Status RECRUITING Phase PHASE1
NCT05694234 Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study Status COMPLETED Phase N/A
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05566964 Descriptive Analysis of Real-world Data Collected with ME&MGopen Status COMPLETED Phase N/A
NCT05564936 The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis Status RECRUITING Phase NA
NCT05455840 A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT05408702 Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes Status COMPLETED Phase N/A
NCT05337891 Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis Status RECRUITING Phase N/A
NCT05332210 Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis Status COMPLETED Phase PHASE3
NCT05324176 Diaphragm Thickness by Ultrasonography in Neurological Disorders Status COMPLETED Phase NA
NCT05265273 A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis Status RECRUITING Phase PHASE2/PHASE3
NCT05218096 Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis Status TERMINATED Phase PHASE2
NCT05214612 Predictors and Prognostic Factors of Myasthenia Gravis Outcome Status RECRUITING Phase N/A
NCT05132569 Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis Status TERMINATED Phase PHASE3
NCT05045248 Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis Status COMPLETED Phase PHASE2
NCT05039190 Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients Status COMPLETED Phase PHASE3